BRAF and leukoencephalopathy with calcifications and cysts: Unfortunately, we didn’t find significant differences between the OS of the BRAF-mutated patients with immunotherapy and those with non-immunotherapy in RCC or LCC cohort, it is most likely because of small sample size of BRAF-mutated patients with immunotherapy.